EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Homeland Security HOM
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BARNES New | — |
| MATTHEW FITTING | — |
| CHRIS FRECH | — |
Disaster Planning/Emergencies DIS
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BARNES New | — |
| MATTHEW FITTING | — |
| CHRIS FRECH | — |
Budget/Appropriations BUD
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BARNES New | — |
| MATTHEW FITTING | — |
| CHRIS FRECH | — |
Health Issues HCR
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BARNES New | — |
| MATTHEW FITTING | — |
| CHRIS FRECH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.